BeOne Medicines ONC
NASDAQ ONC
$359.97 -5.03 (-1.38%)
At close: Sep 24, 2026 · 4:00 PM EDT

BeOne Medicines (ONC) Other Non Operating Income (2015 - 2026)

BeOne Medicines' (ONC) quarterly Other Non Operating Income came in at -$749000.0 in Q2 2026, down 109.17% year-over-year from $8.2 million in Q2 2025, and down 105.15% quarter-over-quarter from $14.5 million in Q1 2026.

Analysis

BeOne Medicines (ONC) Other Non Operating Income (2015 - 2026) Analysis & Trends

BeOne Medicines (ONC) has reported Other Non Operating Income for 12 consecutive years, with -$749000.0 the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Other Non Operating Income fell 109.17% year-over-year to -$749000.0 in Q2 2026; TTM through Jun 2026 was -$40.9 million, a 521.43% decrease from a year earlier, with the FY2025 full-year figure at -$42.6 million, down 236.71% from the prior year.
  • Other Non Operating Income was -$749000.0 for Q2 2026 at BeOne Medicines, down from $14.5 million in the prior quarter.
  • Over five years, Other Non Operating Income peaked at $336.7 million in Q3 2023 and troughed at -$129.6 million in Q2 2022.
  • A 5-year average of $2.4 million and a median of $2.9 million in 2024 frame the typical range for Other Non Operating Income.
  • The widest YoY moves for Other Non Operating Income: up 390.25% in 2022, down 14850.06% in 2022.
  • Over 5 years, Other Non Operating Income stood at $19.4 million in 2022, then dropped by 13.83% to $16.7 million in 2023, then tumbled by 182.0% to -$13.7 million in 2024, then plunged by 159.87% to -$35.7 million in 2025, then surged by 97.9% to -$749000.0 in 2026.
  • The last three Other Non Operating Income figures came in at -$749000.0 (Q2 2026), $14.5 million (Q1 2026), and -$35.7 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 649.01 Bn 628.25 Bn 17.26 Bn
2 AbbVie 468.55 Bn 462.03 Bn 12.70 Bn
3 Merck 365.49 Bn 358.40 Bn 12.21 Bn
4 Novartis Ag 272.39 Bn 265.10 Bn 11.24 Bn
5 Astrazeneca 253.18 Bn 247.96 Bn 12.86 Bn
6 Amgen 219.53 Bn 205.54 Bn 7.24 Bn
7 Gilead Sciences 187.85 Bn 184.59 Bn 6.22 Bn
8 Pfizer 160.56 Bn 149.16 Bn 10.94 Bn
9 Vertex Pharmaceuticals 130.81 Bn 122.96 Bn 2.84 Bn
10 BeOne Medicines 41.25 Bn 36.15 Bn 1.53 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -749,000.00
Mar 31, 2026 14.54 Mn
Dec 31, 2025 -35.69 Mn
Sep 30, 2025 -18.98 Mn
Jun 30, 2025 8.17 Mn
Mar 31, 2025 3.95 Mn
Dec 31, 2024 -13.73 Mn
Sep 30, 2024 11.32 Mn
Jun 30, 2024 -11.98 Mn
Mar 31, 2024 1.76 Mn
Dec 31, 2023 16.75 Mn
Sep 30, 2023 336.66 Mn
Jun 30, 2023 -63.82 Mn
Mar 31, 2023 18.30 Mn
Dec 31, 2022 19.44 Mn
Sep 30, 2022 -125.64 Mn
Jun 30, 2022 -129.62 Mn
Mar 31, 2022 11.97 Mn
Dec 31, 2021 -10.58 Mn
Sep 30, 2021 31.48 Mn
API Access

BeOne Medicines Other Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-operating-income&ticker=ONC&period=max&api_key=YOUR_API_KEY